Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 47 páginas
Examen

NUR 351 Midterm exam | Q&A | 2026/2027 | Pharmacology in Nursing | ASU | Graded A+

Document preview thumbnail
Vista previa 4 fuera de 47 páginas

This document helps you master the NUR 351 Pharmacology in Nursing midterm exam at Arizona State University via targeted Q&A with detailed rationales. It covers pharmacokinetics and pharmacodynamics principles, autonomic and central nervous system drug classifications, cardiovascular and respiratory pharmacology, adverse drug reactions and drug interactions, medication administration safety and dosage calculations, and nursing implications for special populations across the lifespan. Engineered to maximize retention and sharpen critical understanding, this test pack simplifies complex content, saving preparation time and helping you secure an A on your Midterm Assessment.

Vista previa del contenido

NUR 351 Midterm exam | Q&A | 2026/2027 | Pharmacology in
Nursing | ASU | Graded A+

1. The study of how medications alter function in the body is known as:

A) Pathophysiology

B) Pharmacodynamics

C) Pharmacokinetics

D) Pharmacognosy



Correct Answer: Pharmacodynamics



Rationale: Pharmacodynamics is the study of what the drug does to the body
—its mechanisms of action and effects. Pharmacokinetics is what the body
does to the drug. Pathophysiology studies disease processes, and
pharmacognosy is the study of natural drug sources.



2. Which term describes the movement of a drug from its site of
administration into the bloodstream?

A) Distribution

B) Metabolism

C) Absorption

D) Excretion



Correct Answer: Absorption



Rationale: Absorption is the process by which a drug moves from its
administration site into the bloodstream. Distribution is the transport of the
drug to tissues, metabolism is biotransformation, and excretion is elimination
from the body.

,3. A medication with a high first-pass effect is primarily metabolized in which
organ?

A) Kidney

B) Liver

C) Lungs

D) Heart



Correct Answer: Liver



Rationale: The first-pass effect refers to the extensive metabolism of a drug
by the liver before it reaches systemic circulation. Drugs with high first-pass
metabolism have reduced oral bioavailability and may require alternative
routes of administration.



4. Which route of administration bypasses the first-pass effect entirely?

A) Oral

B) Rectal

C) Intravenous

D) Sublingual



Correct Answer: Intravenous



Rationale: Intravenous administration delivers the drug directly into systemic
circulation, completely bypassing the first-pass effect. Sublingual and rectal
routes partially bypass it, but oral administration is most affected.



5. The time required for the concentration of a drug in the plasma to
decrease by half is known as:

A) Onset of action

,B) Duration of action

C) Half-life

D) Therapeutic index



Correct Answer: Half-life



Rationale: Half-life is the time required for the plasma concentration of a
drug to be reduced by 50%. It determines dosing frequency and the time
required to reach steady-state concentration.



6. Which factor is most likely to increase the half-life of a medication?

A) Increased renal function

B) Decreased hepatic function

C) Increased protein binding

D) Decreased volume of distribution



Correct Answer: Decreased hepatic function



Rationale: Decreased hepatic function reduces drug metabolism, prolonging
half-life. Renal impairment affects excretion, decreased protein binding
increases free drug, and increased volume of distribution can also prolong
half-life.



7. The therapeutic index of a drug is calculated as:

A) ED50 / TD50

B) TD50 / ED50

C) LD50 / ED50

D) ED50 / LD50

, Correct Answer: TD50 / ED50



Rationale: The therapeutic index (TI) is the ratio of the toxic dose (TD50) to
the effective dose (ED50). A narrow TI indicates a small margin of safety,
requiring close monitoring of drug levels.



8. A drug with a narrow therapeutic index requires:

A) No special monitoring

B) Frequent monitoring of serum drug levels

C) Administration only by the intravenous route

D) Higher doses to achieve therapeutic effect



Correct Answer: Frequent monitoring of serum drug levels



Rationale: Drugs with a narrow therapeutic index have a small range
between therapeutic and toxic doses. Serum drug levels must be monitored
to ensure efficacy and prevent toxicity. Examples include digoxin, lithium,
and warfarin.



9. Which receptor type is activated by the neurotransmitter acetylcholine at
the neuromuscular junction?

A) Alpha-adrenergic

B) Beta-adrenergic

C) Nicotinic

D) Muscarinic



Correct Answer: Nicotinic

Información del documento

Subido en
18 de agosto de 2026
Número de páginas
47
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$15.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
ExamStudy
3.0
(1)
Vendido
5
Seguidores
0
Artículos
1036
Última venta
7 horas hace



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes